chlortetracycline is a lipid of Polyketides (PK) class. Chlortetracycline is associated with abnormalities such as Granulomatous Disease, Chronic, Infection, Ischemia, Cerebral Ischemia and Cerebral Infarction. The involved functions are known as Regulation, Binding (Molecular Function), Agent, Stimulus and Process. Chlortetracycline often locates in Protoplasm, Plasma membrane, Membrane, Cytoplasm and specific granule. The associated genes with chlortetracycline are FPR1 gene, P4HTM gene, Homologous Gene, HIST1H1C gene and Microbiome. The related lipids are Lysophosphatidylcholines, Sterols, dilauroyl lecithin, seminolipid and Total cholesterol. The related experimental models are Mouse Model.
To understand associated biological information of chlortetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
chlortetracycline is suspected in Ischemia, Cerebral Ischemia, Cerebral Infarction, Granulomatous Disease, Chronic, Infection, Antibiotic resistant infection and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with chlortetracycline
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia.' (Jiang SX et al., 2005).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
McVAY LV and LAIRD RL | The treatment of Trichomonas vaginalis vaginitis with aureomycin. | 1949 | Proc. Soc. Exp. Biol. Med. | pmid:15400831 |
WOMACK CR and KASS EH | A substance in egg yolk which inhibits deterioration of aureomycin activity. | 1949 | Proc. Soc. Exp. Biol. Med. | pmid:15400842 |
MAGOFFIN R et al. | Therapy of experimental brucella infection in the developing chick embryo; therapy with aureomycin. | 1949 | J. Immunol. | pmid:18131601 |
HILL LM and WRIGHT LT | Aureomycin in granuloma inguinale. | 1949 | J Am Med Assoc | pmid:15407146 |
WILLCOX RR | Aureomycin; a new treatment for syphilis? | 1949 | Br Med J | pmid:15395481 |
RUIZ SANCHEZ F and RUIZ SANCHEZ A | [Not Available]. | 1949 | Medicina (Mex) | pmid:18109572 |
FINLAND M et al. | Aureomycin in the treatment of primary atypical pneumonia. | 1949 | N. Engl. J. Med. | pmid:18109605 |
SCHOENBACH EB and BRYER MS | Treatment of primary atypical non-bacterial pneumonia with aureomycin. | 1949 | Am. J. Med. | pmid:18224898 |
DE WIT JC | [Not Available]. | 1949 | Geneeskd Gids | pmid:18143536 |
MARKS JA et al. | Treatment of chronic non-specific ulcerative colitis with aureomycin; a preliminary report. | 1949 | Am. J. Med. | pmid:18136014 |